Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
ImmunOs Therapeutics secures $11 million series C backed by Double Point Ventures, Gimv, Pfizer Ventures, Mission BioCapital, BioMed Partners

ImmunOs Therapeutics secures $11 million series C backed by Double Point Ventures, Gimv, Pfizer Ventures, Mission BioCapital, BioMed Partners

Biotech Health services Pharma

Switzerland

Belgium

United States

Investments

09 September 2024

Share:

ImmunOs Therapeutics (company)

Switzerland

Biotech Health services Pharma

Total investments received (USD): 85m

Round value (USD): 11m

Round investors: BioMedPartners Gimv Pfizer Venture Investments Mission BioCapital Double Point Ventures

Company: ImmunOs Therapeutics

Industry: Biotech Health services Pharma

Related deals

Somagenetix raised CHF10M series A with VI Partners, Zürcher Kantonal Bank, Verve Ventures and Schroders Capital

Biotech Health services

Switzerland

United Kingdom

Investments 02 October 2024

Vandria announced the second closing of its Series A financing with Hevolution Foundation and Dolby Family Ventures joined by ND Capital.

Biotech Health services Manufacturing Pharma

Switzerland

United States

Investments 09 August 2024

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top